搜索到 1000 条关于 88f텔RADARDB◎대출디비II[ 的文章
-
-
2019.06.13 选择性尿液化学物质在肾脏疾病诊断中的应用(1)
,但在了解临床背景后,其可以在评估急性肾损伤(AKI)、机体容积状态、血浆钠钾紊乱以及酸碱失调等方面提供诊断意见。德克萨斯西南医学中心的 Biff F
-
-
2014.11.11 又一个外行成就内行的故事:杜邦豪赌氯沙坦
酶、抑制血管紧张素转化酶(ACE)和拮抗血管紧张素II受体。这引起了一些医药公司的关注。80年代,ACE抑制剂率先被研发出来,虽然副作用依然严重,但还是取得了商业上的成功。此时血管紧张素II受体拮抗剂和肾素抑制剂尚未出现。当时,虽然肾素抑制剂的研究尚属空白,但血管紧张素II的结构和机制已颇为清晰
-
2013.06.03 2013中加健康研究合作计划项目初审结果公布
项目初审的相关规定,对以下88项申请予以受理:序号科学部编号...88813111074朱青安
-
2013.03.13 2013年分子药理学戈登研究研讨会
biology, ii) Cell signalling and trafficking, iii) Physiological
-
-
2021.11.02 如何准确识别心电危急值?| 长城会 2021
心律失常危急值的识别在临床中尤为重要。早期识别、及时处理能有效地降低猝死等严重心血管事件的发生。在所有心源性猝死的患者中,88% 患者都死于心律失常原因。其中 83% 为恶性室性心律失常,17% 为缓慢性心律失常。在第 32 届长城心脏病学大会上,来自北京大学人民医院心内科的张海澄教授就「心电危急值的识别」一题,做了
-
-
2020.08.27 上海市同仁医院首例经导管主动脉瓣置换术顺利完成
8 月 18 日,上海市同仁医院心血管内科在顾问葛均波院士的帮助下,完成了首例经导管主动脉瓣置换术 (TAVR),成为上海市同级医院里能完成 TAVR 手术的少数医院。经历这次手术的患者是一位 88 岁的老年男性。他因为一次晕倒来看病,才发现有主动脉瓣疾病的。患者平日身体一直很健朗,只是有点血压升高、糖尿病和痛风
-
-
2014.04.21 高校职称评定成权钱交易 待遇差别让教师失底线
据中国之声《新闻纵横》报道,这几天,华中师范大学原校长章开沅自动请辞“资深教授”一事备受关注,这位88岁的老人,先后4次请辞,四天前,他终于卸下了这个一年可享受10万元津贴的头衔,也由此成为中国社科界辞去“资深教授”第一人。在利益面前,说“
-
2012.09.19 16th Congress of the Asian Pacific Society of Respirology


16th Congress of the Asian Pacific Society of Respirology
3 – 6 November, 2011, Shanghai
www.apsr2011.orgWelcome message from the Honorary Congress PresidentOn behalf of the Local Congress Committee, it is my honor to cordially invite you all to the 16th APSR. In its 16th year, the APSR Congress has been welcomed for the third time to China and we consider it a great honor to host this event, for the first time in Shanghai. The Congress venue will be the Shanghai International Convention Center. The APSR, Chinese Society of Respiratory Diseases and Shanghai Medical Association have joined forces as co-organizers of the Congress to bring together physicians, academics, healthcare professionals and decision makers in the field of respiratory medicine from around the world to discuss emerging issues and exchange ideas on current research and clinical topics in respirology.The Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in respirology, primarily in conditions commonly found in the Asia Pacific region. The meeting will invite many distinguished international speakers who are expected to participate and provide insights and expert opinion on a wide range of topics in pulmonary and respiratory medicine.I hope that you will enjoy the Congress and that your interaction with your colleagues from different countries will stimulate a creative exchange of ideas and will be personally rewarding. I also trust that you will enjoy your visit to the beautiful and exciting city of Shanghai, in November 2011.

Prof. Zhong Nanshan
Honorary Congress President, APSR 2011
Welcome message from the Congress PresidentIt is my great pleasure and honor as Congress President, to welcome you to the 16th Congress of the Asian Pacific Society of Respirology (APSR). The APSR is renowned as a dynamic organization showcasing the breadth and depth of respiratory medicine across the Asia Pacific region. Following the success of the two previous meetings held in China, this year’s congress hosted by Chinese Society of Respiratory Diseases (CSRD) and Shanghai Medical Association, will be held at the Shanghai International Convention Center, in the vibrant and international metropolis of Shanghai. Since its inception and first meeting held in Tokyo in 1988, the congress has gone from strength to strength and we are expecting this year’s meeting to be no exception and continue this momentum to be an outstanding success.Scheduled for the 3 – 6 November 2011, this four-day congress will feature a comprehensive scientific program, including post-graduate courses, lectures and symposia conducted by key note speakers, who are experts in the field of respirology. In addition, oral and poster presentations will provide exposure for researchers, as a platform for academic exchange on exciting new topics currently under investigation. The organizing committee has organized a range of social events and tours to encourage participants to experience the diverse local culture and traditions of the host city.I hope this Congress will be an exciting and productive gathering of respirologists from the Asia Pacific Region and provide an opportunity to share their knowledge, experience and views on current respiratory disease topics, and provide a platform for networking and collaboration between academics and physicians across the region.I would like to thank the APSR 2011 Local Congress Committee for their dedication and support in making this Congress a success and I would also like to thank all participants for their continued interest and involvement in these meetings and look forward to meeting you in November in Shanghai.We invite you to visit the website (www.apsr2011.org) regularly for the latest updates and news about the organization of the Congress.See you in Shanghai in 2011

Prof. Bai Chunxue
Congress President, APSR 2011
-
-
2019.08.22 EGFR-TKI + 血管靶向药,疗效能否 1+1>2?
一代 EGFR-TKI 与血管靶向治疗的联合有较多的探索,但这一联合治疗策略真的能否给患者带来生存获益么?笔者就最新的临床研究结果与大家探讨一下。贝伐单抗联合厄洛替尼 II 期研究JO25567 研究率先探索了贝伐单抗联合厄洛替尼的疗效及安全性 1。这项 II 期临床研究共纳入 150 例携带 19del 或 21L858R 突变的
-
-
2016.06.03 凝血因子Ⅷ IgA:获得性血友病预后不良的标记物
IU/dL。所有患者存在至少一种类型的 FⅧ抗体。分别有 98% 和 88% 的患者存在 IgG4 和 IgG1,为最高滴度水平的抗体(1:5120...改良的 Bethesda 分析法是目前检测 FⅧ 中和抗体的标准方法,但抑制物水平与 FⅧ水平和出血症状无关联,且无法预测治疗反应。近期,德国汉诺威医学院的
-
-
2014.07.15 治疗基因1型HCV:无干扰素方案是否值得等待?
还是等待无干扰素方案(2015年)?是所有的患者无论肝纤维化程度如何都应当与予新的DAA治疗还是仅治疗纤维化程度≥F2的患者?法国学者就此展开成本效益分析,评价...根据诊断时的纤维化程度及不同进展程度确定开始治疗时机,以及不考虑纤维化程度的不同治疗方案。研究发现,对于肝纤维化阶段≥F2的患者,以干扰素为基础的新DAA方案较
-
-
2014.03.29 中国请辞资深教授第一人:请辞是自我革命
2013年10月02日,武汉华中师范大学,历史学家、华中师范大学教授章开沅在发表讲话。■ 人物章开沅 88岁,历史学家,华中师范大学原校长、资深教授。在辛亥革命史研究、中国资产阶级研究、南京大屠杀历史文献等多个领域都有开创性的学术贡献。2014年寒假前递交书面申请,请辞
-
-
2014.08.06 帕金森病早期诊断准确率不足三成
。该研究提供了II类证据表明,病理证实为PD的患者其临床诊断的敏感性为88%,特异性为68%。...的“很可能PD”患者中,8例(53%)确诊为PD;而在92例病程≥5年的“很可能PD”患者中,72例(88%)确诊为PD。如果采用死亡时的最终诊断,107例
-
-
2020.08.27 小鼠脾细胞 Treg 检测步骤中文
http://special.dxycdn.com/topic/undefined/resource/202008/5-%E5%B0%8F%E9%BC%A0%E8%84%BE%E7%BB%86%E8%83%9ETreg%E6%A3%80%E6%B5%8B%E6%AD%A5%E9%AA%A4%E4%B8%AD%E6
-
-
2020.08.27 Th17 检测原理和样品处理方法
http://special.dxycdn.com/topic/undefined/resource/202008/2-Th17%E6%A3%80%E6%B5%8B%E5%8E%9F%E7%90%86%E5%92%8C%E6%A0%B7%E5%93%81%E5%A4%84%E7%90%86%E6%96%B9%E6
